Kliniceskaa Mikrobiologia i Antimikrobnaa Himioterapia

Aims & Scope

The main purpose of the academic journal "Clinical Microbiology and Antimicrobial Chemotherapy" is to cover the issues related to clinical microbiology and infectious diseases problems.

CMAC is a journal for therapeutists, surgeons, clinical pharmacologists, obstetrician-gynecologists, urologists, microbiologists, dermatovenerologists, ORT specialists, infectious diseases specialists, pediatricians, epidemiologists.

The journal contains original articles, guidelines and reviews.

CMAC presents actual official information from the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy and Institute of Antimicrobial Chemotherapy.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal does not charge a mandatory Article Processing Charge (APC). However, optional open access publication may incur fees based on the publisher’s policies.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• AMRmap – antibiotic resistance surveillance system in Russia

  Citation: 52

  Authors: Alexey Yu., Alina G., Ivan V., Mikhail V., Andrey A., Andrey V., Roman S.

• Antimicrobial resistance of nosocomial Enterobacterales isolates in Russia: results of multicenter epidemiological study “MARATHON 2015–2016”

  Citation: 51

  Authors: M.V., M.V., N.V., E.Yu., E.R., I.S., E.A., A.Yu., A.V., R.S., N.V., S.A., N.V., V.V., N.Z., N.Z., E.Yu., S.M., S.G., M.G., Z.Z., M.V., R.M., I.A., E.V., I.A., A.V., O.A., N.N., Yu.L., E.V., G.Sh., G.G., L.D., E.V., Yu.E., D.Yu., L.N., G.Yu., N.A., V.P., M.G., O.Yu., N.I., T.N., O.V., T.M., E.M., E.N., O.I., T.A., N.M., K.O., L.V., S.A., R.M., L.V., E.G., V.A., I.V., O.V., P.A., V.G., U.S., S.Kh.

• Antimicrobial resistance of pathogens causing community-acquired urinary tract infections in Russia: results of the multicenter study “DARMIS-2018”

  Citation: 37

  Authors: I.S., M.V., A.V., M.V., T.S., R.S.

• AMRcloud: a new paradigm in monitoring of antibiotic resistance

  Citation: 25

  Authors: A.Yu., A.G., I.V., A.A., M.V., A.V., R.S.

• Consumption of systemic antibiotics in the Russian Federation in 2017–2021

  Citation: 22

  Authors: Ivan A., Svetlana A., Roman S., Yu.A.

• Antimicrobial resistance of Haemophilus influenzae clinical isolates in Russia: the results of multicenter epidemiological study «PEHASus 2014–2017»

  Citation: 21

  Authors: Nataly V., Marina V., Aida N., Andrey V., Roman S., М.V., G.G., М.G., А.F., N.А., L.М., G.Sh., О.I., А.V., О.А., Е.N., Т.А., О.V., Yu.L.

• Antimicrobial resistance, carbapenemase production, and genotypes of nosocomial Pseudomonas aeruginosa isolates in Russia: results of multicenter epidemiological study “MARATHON 2015–2016”

  Citation: 21

  Authors: M.V., E.A., M.V., E.Yu., N.V., E.R., A.V., A.Yu., A.V., R.S., N.V., S.A., N.V., V.V., N.A., N.Z., E.Yu., S.M., S.G., M.G., Z.Z., M.V., R.M., I.A., E.V., I.A., A.V., O.A., N.N., Yu.L., E.V., G.Sh., G.G., L.D., E.V., Yu.E., D.Yu., L.N., G.Yu., N.A., V.P., M.G., O.Yu., N.I., T.N., O.V., T.M., E.M., E.N., O.I., T.A., N.M., K.O., L.V., S.A., R.M., L.V., E.G., V.A, I.V., O.V., P.A., V.G., U.S., S.Kh

• Efficacy of methylprednisolone pulse therapy in patients with COVID-19

  Citation: 19

  Authors: Andrey A., E.Z., M.L., S.A., M.M., E.V., I.V., V.Yu., I.N.

• Antimicrobial resistance, carbapenemase production, and genotypes of nosocomial Acinetobacter spp. isolates in Russia: results of multicenter epidemiological study ”MARATHON 2015–2016”

  Citation: 19

  Authors: E.A., M.V., M.V., E.Yu., N.V., E.R., A.Yu., A.V., R.S., N.V., S.A., N.V., V.V., N.A., N.Z., E.Yu., S.M., S.G., M.G., Z.Z., M.V., R.M., I.A., E.V., I.A., A.V., O.A., N.N., Yu.L., E.V., G.Sh., G.G., L.D., E.V., Yu.E., D.Yu., L.N., G.Yu., N.A., V.P., M.G., O.Yu., N.I., T.N., O.V., T.M., E.M., E.N., O.I., T.A., N.M., K.O., L.V., S.A., R.M., L.V., E.G., V.A., I.V., O.V., P.A., V.G., U.S., S.Kh.

• The reasons why Klebsiella pneumoniae becomes a leading opportunistic pathogen

  Citation: 19

  Authors: Igor V., Yu.A., I.V., D.A.